Literature DB >> 15723556

Use of binding enthalpy to drive an allosteric transition.

Patrick H Brown1, Dorothy Beckett.   

Abstract

The Escherichia coli biotin repressor is an allosteric DNA binding protein and is activated by the small molecule bio-5'-AMP. Binding of this small molecule promotes transcription repression complex assembly between the repressor and the biotin operator of the biotin biosynthetic operon. The ability of the adenylate to activate the assembly process reflects its effect on biotin repressor dimerization. Thus concomitant with small molecule binding the free energy of repressor dimerization becomes more favorable by approximately -4 kcal/mol. The structural, dynamic, and energetic changes in the repressor monomer that accompany allosteric activation are not known. In this work the thermodynamics of binding of four allosteric activators to the repressor have been characterized by isothermal titration calorimetry. While binding of two of the effectors results in relatively modest activation of the dimerization process, binding of the other two small molecules, including the physiological effector, leads to large changes in repressor dimerization energetics. Results of the calorimetric measurements indicate that strong effector binding is accompanied by an enthalpically costly transition in the protein. This transition is "paid for" by the enthalpy that would have otherwise been realized from the formation of noncovalent bonds between the ligand and repressor monomer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723556     DOI: 10.1021/bi047792k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

Review 1.  Adenylating enzymes in Mycobacterium tuberculosis as drug targets.

Authors:  Benjamin P Duckworth; Kathryn M Nelson; Courtney C Aldrich
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

Review 2.  Allostery: absence of a change in shape does not imply that allostery is not at play.

Authors:  Chung-Jung Tsai; Antonio del Sol; Ruth Nussinov
Journal:  J Mol Biol       Date:  2008-02-29       Impact factor: 5.469

3.  Kinetic partitioning between alternative protein-protein interactions controls a transcriptional switch.

Authors:  Huaying Zhao; Dorothy Beckett
Journal:  J Mol Biol       Date:  2008-05-03       Impact factor: 5.469

4.  Allosteric signaling in the biotin repressor occurs via local folding coupled to global dampening of protein dynamics.

Authors:  Olli Laine; Emily D Streaker; Maryam Nabavi; Catherine C Fenselau; Dorothy Beckett
Journal:  J Mol Biol       Date:  2008-05-17       Impact factor: 5.469

5.  Distinguishing the interactions in the fructose 1,6-bisphosphate binding site of human liver pyruvate kinase that contribute to allostery.

Authors:  Arjun Ishwar; Qingling Tang; Aron W Fenton
Journal:  Biochemistry       Date:  2015-02-12       Impact factor: 3.162

6.  Allosteric regulation of human liver pyruvate kinase by peptides that mimic the phosphorylated/dephosphorylated N-terminus.

Authors:  Charulata B Prasannan; Qingling Tang; Aron W Fenton
Journal:  Methods Mol Biol       Date:  2012

7.  Sequence-function relationships in folding upon binding.

Authors:  Christopher Eginton; Saranga Naganathan; Dorothy Beckett
Journal:  Protein Sci       Date:  2014-12-26       Impact factor: 6.725

8.  Bisubstrate adenylation inhibitors of biotin protein ligase from Mycobacterium tuberculosis.

Authors:  Benjamin P Duckworth; Todd W Geders; Divya Tiwari; Helena I Boshoff; Paul A Sibbald; Clifton E Barry; Dirk Schnappinger; Barry C Finzel; Courtney C Aldrich
Journal:  Chem Biol       Date:  2011-11-23

9.  Nucleation of an allosteric response via ligand-induced loop folding.

Authors:  Saranga Naganathan; Dorothy Beckett
Journal:  J Mol Biol       Date:  2007-07-26       Impact factor: 5.469

10.  Bisubstrate Inhibitors of Biotin Protein Ligase in Mycobacterium tuberculosis Resistant to Cyclonucleoside Formation.

Authors:  Ce Shi; Divya Tiwari; Daniel J Wilson; Christopher L Seiler; Dirk Schnappinger; Courtney C Aldrich
Journal:  ACS Med Chem Lett       Date:  2013-12-12       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.